ArticleThe Journal of clinical investigation2026
Targeting PIM2 improves antitumor immunity through promoting effector function and persistence of CD8 T cells.
Yongxia Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it